Wedbush Upgrades Fate Therapeutics (FATE) to Outperform

May 7, 2021 4:01 AM EDT
Get Alerts FATE Hot Sheet
Price: $79.57 -4.14%

Rating Summary:
    15 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 25 | New: 41
Trade Now! 
Join SI Premium – FREE

Wedbush analyst David Nierengarten upgraded Fate Therapeutics (NASDAQ: FATE) from Neutral to Outperform with a price target of $88.00.


For an analyst ratings summary and ratings history on Fate Therapeutics click here. For more ratings news on Fate Therapeutics click here.


Shares of Fate Therapeutics closed at $76.55 yesterday.


You May Also Be Interested In





Related Categories

Upgrades